TriApex Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
246
- Latest Deal Type
-
Series C
- Investors
-
26
TriApex General Information
Description
Provider of preclinical research-based research and development (R&D) services designed for the global biopharmaceutical and medical device R&D. The company focuses on pre-clinical research, and its business scope covers services from non-human primate disease models, pharmacological efficacy, early drug evaluation and good laboratory practices (GLP) toxicology to translational medicine, clinical trials, biological analysis, central laboratories and biological sample banks, providing biopharmaceutical developers with technology support.
Contact Information
Website
zh.tri-apex.comCorporate Office
- No. 9 Xinglong Road
- Jiangbei New District
- Nanjing, Jiangsu
- China
Corporate Office
- No. 9 Xinglong Road
- Jiangbei New District
- Nanjing, Jiangsu
- China
TriApex Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series C) | 27-Apr-2023 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 01-Oct-2021 | Completed | Generating Revenue | |||
| 1. IPO | 08-Jan-2016 | $6.18M | $6.18M | Completed | Profitable |
TriApex Comparisons
Industry
Financing
Details
TriApex Competitors (27)
One of TriApex’s 27 competitors is Giant Med-Pharma Services, a Venture Capital-Backed company based in Beijing, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Giant Med-Pharma Services | Venture Capital-Backed | Beijing, China | ||||
| North American Science Associates | Private Equity-Backed | Toledo, OH | ||||
| Patheon | Formerly PE-Backed | Waltham, MA | ||||
| CTI Clinical Trial and Consulting | Private Equity-Backed | Covington, KY | ||||
| CellCarta | Private Equity-Backed | Montreal, Canada |
TriApex Signals
TriApex Investors (26)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Haomai Wealth | PE-Backed Company | Minority | ||
| Hillhouse Investment Group | PE/Buyout | Minority | ||
| Legend Capital | Venture Capital | Minority | ||
| Lingang Technology Innovation Center | Venture Capital | Minority | ||
| Pacific Asset Management | Asset Manager | Minority |
TriApex Investments (2)
TriApex’s most recent deal was a Early Stage VC with Hepo Biology. The deal was made on 28-Aug-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Hepo Biology | 28-Aug-2026 | Early Stage VC | Biotechnology | ||
| Xellar Biosystems | 16-Jul-2024 | Early Stage VC | Discovery Tools (Healthcare) |
TriApex FAQs
-
When was TriApex founded?
TriApex was founded in 2008.
-
Where is TriApex headquartered?
TriApex is headquartered in Nanjing, China.
-
What is the size of TriApex?
TriApex has 246 total employees.
-
What industry is TriApex in?
TriApex’s primary industry is BPO/Outsource Services.
-
Is TriApex a private or public company?
TriApex is a Private company.
-
What is TriApex’s current revenue?
The current revenue for TriApex is .
-
How much funding has TriApex raised over time?
TriApex has raised $105M.
-
Who are TriApex’s investors?
Haomai Wealth, Hillhouse Investment Group, Legend Capital, Lingang Technology Innovation Center, and Pacific Asset Management are 5 of 26 investors who have invested in TriApex.
-
Who are TriApex’s competitors?
Giant Med-Pharma Services, North American Science Associates, Patheon, CTI Clinical Trial and Consulting, and CellCarta are some of the 27 competitors of TriApex.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process